| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PRP.2007.06.001 |
| P698 | PubMed publication ID | 17629419 |
| P2093 | author name string | Albert Roessner | |
| Doerthe Kuester | |||
| Frank Meyer | |||
| Regine Schneider-Stock | |||
| Hans Lippert | |||
| Angela Poehlmann | |||
| P433 | issue | 7 | |
| P921 | main subject | pyrosequencing | Q2342248 |
| colorectal cancer | Q188874 | ||
| colorectal carcinoma | Q25493920 | ||
| P304 | page(s) | 489-497 | |
| P577 | publication date | 2007-07-12 | |
| P1433 | published in | Pathology, Research and Practice | Q15758752 |
| P1476 | title | K-ras mutation detection in colorectal cancer using the Pyrosequencing technique | |
| P478 | volume | 203 |
| Q35584153 | A review of the most promising biomarkers in colorectal cancer: one step closer to targeted therapy |
| Q33999493 | Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status |
| Q33732199 | Analyses of clinicopathological, molecular, and prognostic associations of KRAS codon 61 and codon 146 mutations in colorectal cancer: cohort study and literature review |
| Q28740430 | Benchmarking of mutation diagnostics in clinical lung cancer specimens |
| Q36186908 | Can Serum be Used for Analyzing the KRAS Mutation Status in Patients with Advanced Colorectal Cancer? |
| Q34347975 | Clinical and metabolic parameters in non-small cell lung carcinoma and colorectal cancer patients with and without KRAS mutations |
| Q33875090 | Clinical utility of KRAS and BRAF mutations in a cohort of patients with colorectal neoplasms submitted for microsatellite instability testing |
| Q34200895 | Comparative analysis of dideoxy sequencing, the KRAS StripAssay and pyrosequencing for detection of KRAS mutation |
| Q33913610 | Comparison of HER2 expression between primary colorectal cancer and their corresponding metastases |
| Q36385034 | Detecting KRAS mutations in peripheral blood of colorectal cancer patients by peptide nucleic acid clamp PCR |
| Q33541307 | Dietary, lifestyle and clinicopathological factors associated with BRAF and K-ras mutations arising in distinct subsets of colorectal cancers in the EPIC Norfolk study |
| Q39416581 | Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method |
| Q35587176 | Extended RAS and BRAF Mutation Analysis Using Next-Generation Sequencing |
| Q33465331 | Fast simultaneous detection of K-RAS mutations in colorectal cancer |
| Q86492904 | Frequency of KRAS mutations in adult Korean patients with acute myeloid leukemia |
| Q90950820 | Genomic characterization of intrinsic and acquired resistance to cetuximab in colorectal cancer patients |
| Q54301071 | Involvement of K-RAS mutations and amino acid substitutions in the survival of metastatic colorectal cancer patients. |
| Q33759960 | KRAS analysis in colorectal carcinoma: analytical aspects of Pyrosequencing and allele-specific PCR in clinical practice |
| Q84311638 | KRAS assay selection: sensitivity and accuracy in clinical application |
| Q39642103 | KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis |
| Q37273361 | KRAS mutation testing for predicting response to anti-EGFR therapy for colorectal carcinoma: proposal for an European quality assurance program. |
| Q34532108 | Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer |
| Q33856261 | Mutation detection of epidermal growth factor receptor and KRAS genes using the smart amplification process version 2 from formalin-fixed, paraffin-embedded lung cancer tissue |
| Q33652949 | Mutations in the WTX-gene are found in some high-grade microsatellite instable (MSI-H) colorectal cancers |
| Q90047164 | NUDT7 Loss Promotes KrasG12D CRC Development |
| Q92757568 | Resveratrol Targets Urokinase-Type Plasminogen Activator Receptor Expression to Overcome Cetuximab-Resistance in Oral Squamous Cell Carcinoma |
| Q33569235 | SNP identification, verification, and utility for population genetics in a non-model genus |
| Q53260087 | Up and downregulation of p16(Ink4a) expression in BRAF-mutated polyps/adenomas indicates a senescence barrier in the serrated route to colon cancer. |
| Q37031288 | Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer |
| Q35905048 | Validation of a Multiplex Allele-Specific Polymerase Chain Reaction Assay for Detection of KRAS Gene Mutations in Formalin-Fixed, Paraffin-Embedded Tissues from Colorectal Cancer Patients |
Search more.